H STEWART PARKER Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for H STEWART PARKER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of H STEWART PARKER. H STEWART PARKER is a Director in Armata Pharmaceuticals, Inc. ($APHB) and a President & CEO in AmpliPhi Biosciences Corp ($APHB) and a Director in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and a Director in SANGAMO BIOSCIENCES INC ($SGMO) and a Director in IMPEL NEUROPHARMA INC ($IMPL).
Address: 1100 OLIVE WAY SUITE 100 SEATTLE 98101 WA
Companies in which H STEWART PARKER is an Insider
ACHIEVE LIFE SCIENCES, INC.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of H STEWART PARKER: Director
Holdings: 12,500 shares
Current Value: $7,500
Latest Transaction: May 14 2020
$ACHV Market Capitalization: $18.31M
$ACHV Previous Close: $0.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Armata Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of H STEWART PARKER: Director, President & CEO
Holdings: 131,175 shares
Current Value: $70,835
Latest Transaction: May 24 2019
$APHB Market Capitalization: $5.61M
$APHB Previous Close: $0.54
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMPEL NEUROPHARMA INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of H STEWART PARKER: Director
Holdings: 3,732 shares
Latest Transaction: Apr 29 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SANGAMO THERAPEUTICS, INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of H STEWART PARKER: Director
Holdings: 31,200 shares
Current Value: $120,120
Latest Transaction: Mar 01 2021
$SGMO Market Capitalization: $254.24M
$SGMO Previous Close: $3.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of H STEWART PARKER
Sentiment: All, ACHV, APHB, IMPL, SGMO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Option Exercise | C | 0.00 | 143,986 | 0 | 0 | |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Option Exercise | X | 0.00 | 47,236 | 0 | 143,986 | |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Option Exercise | X | 0.00 | 47,263 | 0 | 0 | |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Option Exercise | C | 0.00 | 120,447 | 0 | 0 | |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Option Exercise | X | 0.00 | 13,756 | 0 | 120,447 | |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Option Exercise | X | 0.00 | 13,756 | 0 | 0 | |
| Apr 29 2021 | IMPL | IMPEL NEUROPHARMA ... | PARKER H STEWART | Director | Option Exercise | C | 0.00 | 61,109 | 0 | 0 |